Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/5204
Title: | 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties | Authors: | Kasaplar, Pınar Yılmazer, Özgür Çağır, Ali |
Keywords: | (R)-Goniothalamin Cancer cell lines Conformationally constrained analogues Cytotoxic activity |
Issue Date: | Jan-2009 | Publisher: | Elsevier Ltd. | Source: | Kasaplar, P., Yılmazer, Ö. and Çağır, A.(2009). 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties. Bioorganic and Medicinal Chemistry, 17(1), 311-318. doi:10.1016/j.bmc.2008.10.069 | Abstract: | (R)-Goniothalamin, is a member of styryl lactones, possesses selective cytotoxicity against cancer cell lines. In this work, replacement of styryl substituent with 2-naphthyl and 3-quinoyl gave new analogues which may have less conformational changes compared to the lead compound. Anti-proliferative tests indicated that 2-naphthyl substituted (R)-5,6-dihydro-2H-pyran-2-one has slightly better cytotoxicity than (R)-goniothalamin. To clarify the effect of 2-naphthyl substituent additional aryl substituted (R)-5,6-dihydro-2H-pyran-2-ones have been synthesized enantioselectively and tested against PC-3 and MCF-7 cell lines. | URI: | http://dx.doi.org/10.1016/j.bmc.2008.10.069 http://hdl.handle.net/11147/5204 |
ISSN: | 0968-0896 0968-0896 |
Appears in Collections: | Chemistry / Kimya PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
32
checked on May 27, 2023
WEB OF SCIENCETM
Citations
30
checked on May 27, 2023
Page view(s)
1,110
checked on May 22, 2023
Download(s)
190
checked on May 22, 2023
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.